Showing results (311-320 of 330) with videos related to

Sort By:
Pageof 33
The Review of Scientific Instruments|May 2, 2008
Ultra-high-precision time control system over any long time delay for laser pump and synchrotron x-ray probe experimentYoshimitsu Fukuyama, Nobuhiro Yasuda, Jungeun Kim, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2007
Synthesis and biological evaluation of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel PI3 kinase p110alpha inhibitorsMasahiko Hayakawa, Hiroyuki Kaizawa, Hiroyuki Moritomo, et al.
Bioorganic & Medicinal Chemistry|June 14, 2015
Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3Yutaka Nakajima, Takayuki Inoue, Kazuo Nakai, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2002
Positional cloning of the gene LIMBIN responsible for bovine chondrodysplastic dwarfismHaruko Takeda, Marika Takami, Tomoko Oguni, et al.
The Journal of Veterinary Medical Science|January 13, 2005
Serodiagnosis of Babesia gibsoni infection in dogs by an improved enzyme-linked immunosorbent assay with recombinant truncated P50Rodolfo A Verdida, Olgga A Hara, Xuenan Xuan, et al.
Bioorganic & Medicinal Chemistry|August 10, 2017
Discovery of tricyclic dipyrrolopyridine derivatives as novel JAK inhibitorsHiroaki Yamagishi, Takayuki Inoue, Yutaka Nakajima, et al.
Physical Review Letters|February 21, 2006
Nanomagnetic droplets and implications to orbital ordering in LA(1-x)Sr(x)CoO3D Phelan, Despina Louca, S Rosenkranz, et al.
Bioorganic & Medicinal Chemistry|April 13, 2020
Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2Ikumi Kuriwaki, Minoru Kameda, Hiroyuki Hisamichi, et al.
Bioorganic & Medicinal Chemistry|October 17, 2025
Structure-based design, synthesis, and evaluation of tetrahydrotriazolothiazepine derivatives as novel 11β-hydroxysteroid dehydrogenase type 1 inhibitorsYukinobu Numata, Toru Hasegawa, Makoto Mori, et al.
Bioorganic & Medicinal Chemistry|January 24, 2021
Synthesis and structure-activity relationships of pyrimidine derivatives as potent and orally active FGFR3 inhibitors with both increased systemic exposure and enhanced in vitro potencyIkumi Kuriwaki, Minoru Kameda, Kazuhiko Iikubo, et al.
Pageof 33